ADVA
5.5.2022 09:02:06 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that it’s playing a key role in three research and development (R&D) projects building future-proof secure communication networks based on quantum key distribution (QKD). Funded by Germany’s Federal Ministry of Education and Research (BMBF), the initiatives aim to address the significant cybersecurity threat posed by quantum hacking and create the next generation of quantum-safe transport infrastructure with technology made in Germany. In cooperation with other consortium partners, ADVA will accelerate the commercial adoption of QKD technology by making it deployable at scale, robust and easy to integrate.
“The looming threat of large quantum computers puts our most sensitive data at risk. There’s also the immediate danger of cybercriminals harvesting encrypted information now so they can decrypt it when quantum computers become accessible. This is why the switch to quantum-safe encryption is essential for the long-term security of critical data. QKD is based on quantum technology and protects the key exchange between communication endpoints. Even if there is future progress in decryption algorithms and computational capabilities, either classical or quantum, an adversary cannot intercept the keys,” said Michael Roth, GM at Network Security, ADVA. “We understand the requirements of both the quantum and the communication world. By lending our technology and know-how, we’re bridging the gap between them. The BMBF-funded initiatives we’re involved in will make QKD usable for commercial and government customers. Together with our partners, we’re moving this technology to the next level for robust, seamless deployment at scale in today’s optical networks.”
Each of the three projects involves a consortium of industry and research partners with leading expertise in quantum technologies, cryptography, optical communication, and network operation. Coordinated by Deutsche Telekom, the DemoQuanDT project will demonstrate secure quantum key exchange over a fiber optic link between Berlin and Bonn and investigate key management in a multi-vendor environment. Led by Infosim, the QuNet+ML project will research methods for optimizing quantum key distribution in large-scale networks using machine learning. And finally, the DE-QOR project led by ADVA will develop compact and cost-effective continuous-variable QKD (CV-QKD) technology compatible with existing metro and long-distance fiber infrastructure.
“QKD offers a way to achieve true long-term network security today. In just a few years, we’re likely to see current public key cryptosystems rendered obsolete by malicious actors with quantum computers, whether that’s criminal organizations seeking profit or state-sponsored actors aiming to infiltrate critical national infrastructure. It’s therefore crucial that we harness quantum technology quickly in order to stay ahead in the cybersecurity race. Our involvement in these latest BMBF projects is testament to ADVA’s role as a leader in this vital R&D space,” commented Helmut Griesser, director of advanced technology at ADVA. “From day one, our ConnectGuard™ encryption technology has been at the forefront of quantum-safe communication by offering an open, standards-based interface to external QKD systems. Leveraging our expertise in coherent transmission, digital signal processing and cryptography, we’re now working towards our own CV-QKD solution to give customers more choice.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005590/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GigaDevice Launches First GD24CL Series I²C EEPROM, Further Expanding Its Non-Volatile Memory Portfolio2.7.2026 16:00:00 CEST | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, announced today the launch of its new GD24CL series I²C EEPROM. The series delivers outstanding performance, comprehensive security protection mechanisms, and excellent reliability that addresses the stringent requirements for stable and long-term storage of critical configuration data. These offered features will benefit applications in industrial, energy, Internet-of-Things (IoT), data centers, and networking. As GigaDevice’s first EEPROM product series, the launch further enhances the company’s non-volatile memory portfolio and provides customers with more dynamic storage solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260702394554/en/ GigaDevice Launches First GD24CL Series I²C EEPROM, Further Expanding Its Non-Volatile Memory Portfolio. The GD24CL series is designed with high
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur® Peripheral Retrievable Scaffold System in a Select CLTI Cohort2.7.2026 13:00:00 CEST | Press release
Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported by a grant, investigates early vessel recoil following below-the-knee treatment using the Spur® Peripheral Retrievable Scaffold System in combination with a commercially available drug-coated balloon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701995624/en/ The study investigates early vessel recoil following below-the-knee treatment using the Spur® Peripheral Retrievable Scaffold System in combination with a commercially available drug-coated balloon. The study plans to enroll up to 40 patients with chronic limb-threatening ischemia (CLTI) across two distinct cohorts: patients with diabetes and patients with end-stage renal disease receiving hemodialysis for at least six months, with women comprisi
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)2.7.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to eight newly hired non-executive employees. The equity awards were granted on July 1, 2026 and consisted of options to purchase an aggregate of 63,685 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 30,300 shares. The options have an exercise price per share equal to $13.29, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted sh
Infobip Launches PitchMate — An AI Fan Companion for Global Football2.7.2026 12:00:00 CEST | Press release
Two AI agents. Two global sports. One platform redefining what it means to be a fan. Global AI-first cloud communications platform Infobip launched PitchMate, a new AI-powered conversational agent that brings football fans closer to the action of the world’s biggest football tournament. Purpose-built for the global football audience, PitchMate joins the TGR Haas F1 Team RaceMate — Infobip’s AI fan engagement solution for the TGR Haas F1 Team — in demonstrating how conversational AI is transforming fan engagement across sports worldwide. RaceMate, launched last April for this year’s motorsport season, is an AI agent on WhatsApp and Apple Messages for Business that puts TGR Haas F1 Team fans at the center of the action. It delivers real-time race data, personalized content, team radio highlights, trivia, and native multilingual support, turning passive viewers into active participants through natural, human-like conversations across every race weekend. Since its launch, RaceMate has reac
Besins Healthcare Strengthens Innovation Capabilities with Acquisition of UniD Manufacturing, a Specialist in Long-Acting Drug Delivery Technologies2.7.2026 11:00:00 CEST | Press release
Acquisition brings together Besins Healthcare's hormonal health leadership and UniD's expertise in the development and manufacturing of advanced polymer based pharmaceutical formulations.1UniD Manufacturing to become Besins Healthcare PharmTech, serving as a strategic innovation hub within the company while continuing to serve its clients. Besins Healthcare, a global pharmaceutical company specializing in hormonal health, today announced the acquisition of UniD Manufacturing, a Belgium-based pharmaceutical development and manufacturing company with more than 20 years of recognized expertise in long-acting drug delivery technologies.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701779777/en/ Besins Healthcare Strengthens Innovation Capabilities with Acquisition of UniD Manufacturing, a Specialist in Long-Acting Drug Delivery Technologies This acquisition brings together two highly compatible areas. Besins Healthcare bri
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
